Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome.
Front Immunol
; 12: 700716, 2021.
Article
in English
| MEDLINE | ID: covidwho-1262607
ABSTRACT
[This corrects the article DOI 10.3389/fimmu.2021.633297.].
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
Front Immunol
Year:
2021
Document Type:
Article
Affiliation country:
Fimmu.2021.700716
Similar
MEDLINE
...
LILACS
LIS